a hundred twenty five. Lengthy-expression monitoring will probably be important for the reason that ruxolitinib decreases normal killer cell features with a potential hazard of good tumor and lymphoma growthAutonomous activation of your JAK/STAT pathway is central in quite a few pathologies. Genetic alterations focusing on this signaling pathway ar